WO2000023062A3 - Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation - Google Patents
Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation Download PDFInfo
- Publication number
- WO2000023062A3 WO2000023062A3 PCT/US1999/024558 US9924558W WO0023062A3 WO 2000023062 A3 WO2000023062 A3 WO 2000023062A3 US 9924558 W US9924558 W US 9924558W WO 0023062 A3 WO0023062 A3 WO 0023062A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antagonist
- pain
- solution
- inflammation
- agonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU12149/00A AU1214900A (en) | 1998-10-20 | 1999-10-20 | Irrigation solution and method for inhibition of pain and inflammation |
EP99970596A EP1434573A2 (fr) | 1998-10-20 | 1999-10-20 | Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation |
US09/839,633 US20020028798A1 (en) | 1995-12-12 | 2001-04-20 | Irrigation solution and method for inhibition of pain and inflammation |
US09/839,633 US7091181B2 (en) | 1994-12-12 | 2001-04-20 | Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors |
US11/410,407 US20060205658A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
US11/409,919 US20060229588A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
US11/410,406 US20060205657A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10504498P | 1998-10-20 | 1998-10-20 | |
US60/105,044 | 1998-10-20 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/024557 Continuation-In-Part WO2000023061A2 (fr) | 1994-12-12 | 1999-10-20 | Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation |
Related Child Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/024625 Continuation-In-Part WO2000023072A1 (fr) | 1994-12-12 | 1999-10-20 | Solution d'irrigation contenant des inhibiteurs de mapk et son utilisation pour traiter la douleur et l'inflammation |
US09/839,633 Continuation-In-Part US20020028798A1 (en) | 1994-12-12 | 2001-04-20 | Irrigation solution and method for inhibition of pain and inflammation |
US11/410,406 Continuation-In-Part US20060205657A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
US11/409,919 Continuation-In-Part US20060229588A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
US11/410,407 Continuation-In-Part US20060205658A1 (en) | 1994-12-12 | 2006-04-24 | Irrigation solution and method for inhibition of pain and inflammation |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000023062A2 WO2000023062A2 (fr) | 2000-04-27 |
WO2000023062A3 true WO2000023062A3 (fr) | 2000-07-27 |
Family
ID=22303751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/024558 WO2000023062A2 (fr) | 1994-12-12 | 1999-10-20 | Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1434573A2 (fr) |
AU (1) | AU1214900A (fr) |
WO (1) | WO2000023062A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2313900T3 (es) | 1999-07-28 | 2009-03-16 | The Board Of Trustees Of The Leland Stanford Junior University | Nicotina en angiogenesis y vasculogenesis terapeutica. |
CA2380052C (fr) * | 1999-07-28 | 2007-10-23 | John Cooke | Agoniste du recepteur de la nicotine, present dans une cellule souche, et mobilisation de cellules souches |
US7838539B2 (en) | 1999-07-28 | 2010-11-23 | The Board Of Trustees Of The Leland Stanford Junior University | Nicotine receptor agonists in stem cell and progenitor cell recruitment |
US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
CA2341952A1 (fr) | 2001-03-23 | 2002-09-23 | Universite Laval | Agonistes du recepteur de la nicotine pour le traitement des maladies pulmonaires inflammatoires |
US8557804B2 (en) | 2002-03-25 | 2013-10-15 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US8039459B2 (en) | 2004-07-15 | 2011-10-18 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
AU2003261304A1 (en) | 2002-07-30 | 2004-02-16 | Omeros Corporation | Ophthalmologic irrigation solutions and method |
US7238715B2 (en) * | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
EP2129381A1 (fr) | 2007-01-24 | 2009-12-09 | Glaxo Group Limited | Nouvelles compositions pharmaceutiques |
AU2013201465B2 (en) | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
TWI705812B (zh) | 2014-12-01 | 2020-10-01 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5820583A (en) * | 1995-12-12 | 1998-10-13 | Omeros Medical Systems, Inc. | Surgical irrigation solution and method for inhibition of pain and inflammation |
-
1999
- 1999-10-20 WO PCT/US1999/024558 patent/WO2000023062A2/fr active Application Filing
- 1999-10-20 EP EP99970596A patent/EP1434573A2/fr not_active Withdrawn
- 1999-10-20 AU AU12149/00A patent/AU1214900A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5820583A (en) * | 1995-12-12 | 1998-10-13 | Omeros Medical Systems, Inc. | Surgical irrigation solution and method for inhibition of pain and inflammation |
Non-Patent Citations (6)
Title |
---|
BONDAREV V I ET AL: "[Disorders of immunoreactivity in acute cholecystitis in middle-aged and elderly patients and their correction in preventing postoperative complications]. Narusheniia immunoreaktivnosti pri ostrom kholetsistite u bol'nykh pozhilogo i starcheskogo vozrasta i ikh korrektsiia v profilatike posleoperats", KLINICHESKAIA KHIRURGIIA, (1990) (9) 27-9., XP002137213 * |
CHIARI A, EISENACH J C: "ANTINOCICEPTIVE EFFECTS OF RJR 2403, A SELECTIVE NICOTINIC AGONIST, IN MALE AND FEMALE RATS.", FASEB JOURNAL, vol. 12, no. 4 PART 1, SUPP. [S], 17 March 1998 (1998-03-17), pages 920, XP000906769 * |
DECKER ET AL: "Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice", EUROPEAN JOURNAL OF PHARMACOLOGY,NL,AMSTERDAM, vol. 346, no. 1, 3 April 1998 (1998-04-03), pages 23 - 33-33, XP002110643, ISSN: 0014-2999 * |
DONNELLY-ROBERTS ET AL: "ABT-594: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,US,AMERICAN SOCIETY FOR PHARMACOLOGY AND, vol. 285, no. 2, May 1998 (1998-05-01), pages 777 - 786-786, XP002105019, ISSN: 0022-3565 * |
HOLLADAY ET AL: "Neuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery", JOURNAL OF MEDICINAL CHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. WASHINGTON, vol. 40, no. 26, 19 December 1997 (1997-12-19), pages 4169 - 4194-4194, XP002124847, ISSN: 0022-2623 * |
ZHANG, XIAO. GONG, ZE-HUI. FASTH, KARL JOHAN. LANGSTROM, BENGT. NORDBER AGNETA: "INTERACTION OF THE NICOTINIC AGONIST (R,S)-3-PYRIDYL-1-METHYL-2-(3-PYRIDYL)-AZETIDINE (MPA) WITH NICOTINIC ACETYLCHOLINE RECEPTOR SUBTYPES EXPRESSED IN CELL LINES AND RAT CORTEX.", NEUROCHEM. INT., vol. 32, no. 5-6, 1998, pages 435 - 441, XP000905243 * |
Also Published As
Publication number | Publication date |
---|---|
EP1434573A2 (fr) | 2004-07-07 |
WO2000023062A2 (fr) | 2000-04-27 |
AU1214900A (en) | 2000-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001007067A3 (fr) | Solutions et procedes permettant d'inhiber la douleur, les inflammations et la degradation des cartilages | |
AU6397496A (en) | Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis | |
WO2000023062A3 (fr) | Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation | |
PT646012E (pt) | Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3 | |
WO2005047244A3 (fr) | Inhibition de recepteur fgfr3 et traitement de myelome multiple | |
HK1008983A1 (en) | Irrigation solution and method for inhibition of pain, inflammation and spasm. | |
WO2005044194A3 (fr) | Traitement ou prevention de la neoplasie a l'aide d'un inhibiteur de la proteine hsp90 | |
WO2002019985A3 (fr) | Procedes permettant d'enrayer une diminution de l'ecoulement d'un medicament par voie transdermique fondes sur l'inhibition de l'obturation du passage | |
CA2229078A1 (fr) | Composition pharmaceutique contenant il-10 | |
ATE227124T1 (de) | Behandlung von multipler sklerose (ms) und anderen demyelinisationserkrankungen unter verwendung von lofepramin in kombination mit l- phenylalamin, tyrosin oder tryptophan und evtl. einer vitamin b12-verbindung | |
WO2000025745A3 (fr) | Solution d'irrigation et methode pour l'inhibition de la douleur et de l'inflammation | |
WO2003092606A3 (fr) | Inhibiteurs de cholinesterase pour prevenir les blessures causees par des produits chimiques | |
CA2179015A1 (fr) | Utilisation de bis(amidinobenzimidazoles) dans la fabrication de medicaments destines a inhiber l'integrase retrovirale | |
RU94044356A (ru) | Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с | |
HK1048259A1 (en) | Irrigation solution and method for inhibition of pain and inflammation. | |
WO2000023061A3 (fr) | Solution et methode d'irrigation destinees a l'inhibition d'une douleur et d'une inflammation | |
SE9101840D0 (sv) | New medicinal use | |
EP1563838A3 (fr) | Solution d'irrigation et méthodes pour inhiber la douleur et l'inflammation | |
WO2003034999A3 (fr) | Medicament et methode de traitement de cicatrices visibles par administration topique transdermique d'inhibiteurs calciques | |
WO2002085292A3 (fr) | Procede ameliore de traitement de manifestations aberrantes du tissu fibreux avec des preparations a base d'agent bloquant topique des canaux de calcium et composition amelioree utilisee dans ce traitement et son procede de fabrication ameliore | |
EP1051995A3 (fr) | Agonistes de récepteur de 5HT 1 et un inhibiteur de la cyclooxygénase-2 pour le traitment de la migraine | |
EP0331803A3 (fr) | Médicament pour empêcher l'attaque et pour traiter la migraine au moyen d'un inhibiteur ace | |
BR0014751A (pt) | Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto | |
CA2251353A1 (fr) | Dispositif pour administration transdermique de composes d'azapirone | |
WO2003093415A3 (fr) | Methodes utilisees dans le traitement et la prevention d'une infection par vih |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref country code: AU Ref document number: 2000 12149 Kind code of ref document: A Format of ref document f/p: F |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999970596 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999970596 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11410407 Country of ref document: US Ref document number: 11409919 Country of ref document: US Ref document number: 11410406 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 11410407 Country of ref document: US Ref document number: 11410406 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 11409919 Country of ref document: US |